Icomb 5 Mg/5 Mg

Ramipril, the active ingredient in Icomb 5 Mg/5 Mg, is an ACE inhibitor presented as a 5 mg/5 mg tablet for oral use. It, together with amlodipine besilate, treats hypertension in adults who need combined blood‑pressure control.

GNH USA supplies Icomb 5 Mg/5 Mg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Icomb 5 Mg/5 Mg combines an ACE inhibitor and a calcium‑channel blocker to manage high blood pressure. It is indicated for: - Essential hypertension: lowers systolic and diastolic pressure in adults. - Uncontrolled hypertension: provides additional reduction when monotherapy is insufficient. - Diastolic hypertension: helps achieve target diastolic values in patients with isolated diastolic elevation.

The combination may cause a range of adverse reactions.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness: especially upon standing. - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet. - Flushing: transient warmth and redness. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, or airway requiring emergency care. - Severe hypotension: marked drop in blood pressure causing faintness. - Hepatic dysfunction: abnormal liver enzymes or jaundice. - Myocardial infarction: rare occurrence of heart attack. - Neutropenia: low white‑blood‑cell count increasing infection risk. - Anaphylaxis: severe allergic reaction with rash, breathing difficulty.

Before prescribing Icomb 5 Mg/5 Mg, clinicians should consider several safety factors. - Pregnancy: category D; avoid unless benefits outweigh risks. - Renal impairment: monitor kidney function and adjust dose if needed. - Hepatic impairment: use with caution; liver function tests recommended. - Electrolyte imbalance: watch serum potassium, especially with diuretics. - Concomitant ACE inhibitors or ARBs: increased risk of hyperkalemia and renal dysfunction. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Icomb 5 Mg/5 Mg can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Aliskiren in diabetic patients: risk of renal failure and hyperkalemia. - Potassium‑sparing diuretics: may cause dangerous hyperkalemia. - Lithium: increased lithium levels and toxicity. - NSAIDs: can blunt antihypertensive effect and affect renal function. - Concurrent ACE inhibitors or ARBs: heightened risk of hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure lowering effect. - Thiazide diuretics: may enhance hypotensive response. - CYP3A4 inhibitors (e.g., erythromycin): can increase amlodipine concentrations. - CYP3A4 inducers (e.g., rifampicin): may reduce amlodipine efficacy. - Antidiabetic agents: blood‑glucose levels may fall, requiring dose adjustment.